What Korean Biopharma Firms Need To Consider Before Deal Negotiations

Licensing Deals Falling, But Firms Actively Moving

 
• By Jung Won Shin
dealmaking
Bioventure License Deal Performance Increasingly Assessed During IPO Filings • Source: Shutterstock

More from Deals

More from Business